Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00883103 · ClinicalTrials.gov registry record · Phase 4
Double Blinded Randomized Trial Between Lidocaine And Plain Gel For Urethral Straight Catheterization And The Q-Tip Test
A Phase 4 study of Pain, sponsored by Baystate Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 137
- Enrollment target
- 1
- Study location
NCT00883103 is a Phase 4 study of Pain that has completed, run by Baystate Medical Center. The registered enrollment target is 137 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00883103, a Phase 4 study of Pain, has completed, sponsored by Baystate Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 137 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the pain perception between lidocaine and plain aqueous gel during assessment of postvoid residual volume and the Q-tip test.
Conditions Studied
Interventions
- DRUG 2% Lidocaine jelly
- DRUG Plain aqueous gel
Study Locations (1)
Massachusetts
- Baystate Medical Center - Springfield
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2007-11 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00883103
The ClinicalTrials.gov registry entry for NCT00883103 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (55% lower). The listed sponsor is Baystate Medical Center, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which 2% Lidocaine jelly is the first listed.
NCT00883103 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00883103 about?
NCT00883103 is a clinical study titled "Double Blinded Randomized Trial Between Lidocaine And Plain Gel For Urethral Straight Catheterization And The Q-Tip Test". The purpose of this study is to compare the pain perception between lidocaine and plain aqueous gel during assessment of postvoid residual volume and the Q-tip test.
What is the current status of trial NCT00883103?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 137 participants. The study started on 2007-11. Estimated completion is 2008-09.
What conditions does trial NCT00883103 study?
This clinical trial studies the following conditions: Pain.
What interventions are being tested in trial NCT00883103?
The interventions under investigation include: 2% Lidocaine jelly (DRUG), Plain aqueous gel (DRUG).
Who is sponsoring clinical trial NCT00883103?
This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00883103 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.